Praxis Precision Medicines (PRAX) Gross Profit: 2023-2025
Historic Gross Profit for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to $4.4 million.
- Praxis Precision Medicines' Gross Profit rose 1365.23% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 1286.92%. This contributed to the annual value of $8.6 million for FY2024, which is 249.53% up from last year.
- Per Praxis Precision Medicines' latest filing, its Gross Profit stood at $4.4 million for Q3 2025, which was down 10.43% from $4.9 million recorded in Q2 2025.
- Over the past 5 years, Praxis Precision Medicines' Gross Profit peaked at $7.5 million during Q4 2024, and registered a low of $302,000 during Q3 2024.
- Over the past 3 years, Praxis Precision Medicines' median Gross Profit value was $683,000 (recorded in 2023), while the average stood at $2.3 million.
- Per our database at Business Quant, Praxis Precision Medicines' Gross Profit tumbled by 54.29% in 2024 and then soared by 1,365.23% in 2025.
- Over the past 3 years, Praxis Precision Medicines' Gross Profit (Quarterly) stood at $515,000 in 2023, then surged by 1,349.13% to $7.5 million in 2024, then skyrocketed by 1,365.23% to $4.4 million in 2025.
- Its Gross Profit stands at $4.4 million for Q3 2025, versus $4.9 million for Q2 2025 and $5.4 million for Q1 2025.